Post-earnings recap
Reported
Thu, Feb 6, 2025
EPS actual
$1.67
EPS est.
$1.46
EPS surprise
+14.15%
1-day move
-3.84%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bristol-Myers Squibb reported better-than-expected earnings per share, exceeding estimates by 14.15%. However, the stock fell by 3.84% following the announcement, indicating that investors may have been disappointed by the lack of revenue information and guidance. The market reaction suggests uncertainty about the company's future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.67 | N/A | +14.15% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.